Xiao-Fan Zhu
Tianjin, Tianjin Municipality, 300000, China
NCT Number: NCT04409379
Compelling epidemiological evidence indicates that alterations of relative telomere length (RTL) are associated with cardiac dysfunction caused by chemotherapy in children with acute leukemia (AL).The aim of this study was to explore association between RTL content in peripheral blood cells could be used as a risk predictor for severity of cardiac damage.
Looking for future studies?
Notify Me1 year–16 year
All sexes
Observational
Tianjin, Tianjin Municipality, 300000, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Relative telomere length in peripheral blood cell
Time frame: From date of admission until the date of discharging from hospital, assessed up to 5 days
The ratio of RTL to hemoglobin contents was calculated for each sample from standard curves. After that, the ratio for each sample was normalized to a calibrator DNA in order to standardize between different runs, and then defined as the measurement of relative mtDNA contents.Relative expression of mtDNA were measured in young adults suffered from AL.
Air Force Military Medical University, China
Other
Association Between Relative Telomere Length and Severity of Cardiac Dysfunction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05923242
Cardiac Toxicity, Cardiotoxicity
St Louis, Missouri, United States
View Trial DetailsNCT01719562
Breast Cancer, Breast Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03235427
Adenocarcinoma, Arterial Occlusive Diseases
Lake Success, New York, United States
View Trial DetailsNCT06183437
Antineoplastics Toxicity, Cancer
Los Angeles, California, United States
View Trial Details